
ImmunityBio, Inc.
IBRXNasdaqCIK 1326110HealthcareFiscal year ends Dec 31
Reports and events: 180 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-08-0716:10 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001564590-17-015981 |
| 2017-06-1316:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-17-202486 |
| 2017-05-0816:31 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001564590-17-009421 |
| 2017-04-2806:06 ET | DEF 14A | Proxy statementPeriod 2017-06-09 | 0001193125-17-145051 |
| 2017-03-1516:17 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001564590-17-004430 |
| 2016-11-1016:01 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001564590-16-028905 |
| 2016-08-2906:07 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-16-694505 |
| 2016-08-1512:01 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001564590-16-024275 |
| 2016-07-1116:24 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-16-645504 |
| 2016-06-2009:00 ET | 8-K | 5.07 Shareholder vote results | 0001193125-16-625855 |
| 2016-05-1612:02 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001564590-16-019464 |
| 2016-04-2709:01 ET | DEF 14A | Proxy statementPeriod 2016-06-15 | 0001193125-16-557867 |
| 2016-03-3013:00 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001564590-16-015596 |
| 2016-03-2916:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-16-521411 |
| 2016-03-1109:02 ET | 8-K | 4.02 Non-reliance on financial statements | 0001193125-16-500957 |
| 2016-01-2516:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-16-436828 |
| 2015-11-2707:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-15-389144 |
| 2015-11-1709:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-15-379180 |
| 2015-11-1206:05 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001564590-15-010422 |
| 2015-10-2317:08 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-15-352134 |
| 2015-09-1021:07 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001564590-15-007836 |
| 2015-08-3116:35 ET | SC 13D | Ownership report, active investor | 0001193125-15-308271 |
| 2015-08-0421:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-15-275314 |
| 2015-07-2714:50 ET | S-1/A | Registration statement, amended | 0001193125-15-263882 |
| 2015-07-2706:26 ET | S-1/A | Registration statement, amended | 0000950123-15-007692 |
| 2015-07-1606:07 ET | S-1/A | Registration statement, amended | 0001193125-15-254266 |
| 2015-07-1506:06 ET | S-1/A | Registration statement, amended | 0001193125-15-252847 |
| 2015-07-1306:10 ET | S-1/A | Registration statement, amended | 0001193125-15-250710 |
| 2015-07-0221:56 ET | S-1/A | Registration statement, amended | 0001193125-15-243390 |
| 2015-06-1917:24 ET | S-1 | Registration statement | 0001193125-15-229037 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.